About Holly K. Miller, DO
Holly Miller, DO, joined Phoenix Children's Hospital in 2015. Her areas of interest include transplants for patients with primary immune deficiency disorders, management of primary immune deficiencies, primary immune dysregulation disorders, bone marrow failure syndromes and cytopenias.
Dr. Miller has authored multiple peer-reviewed manuscripts and abstracts and has participated in several multicenter NIH funded studies. Noting the lack of comprehensive care provided to patients with immune deficiencies and immune dysregulation disorders, she cofounded the Comprehensive Immunohematology Clinic in 2016. In the community, Dr. Miller cofounded Phoenix Children's Hospital annual Locks for Gold event in 2017, where hair donations are collected to provide hair replacement systems to any child with a medical reason for hair loss free of charge.
Dr. Miller is committed to providing excellent and compassionate patient care in the field of pediatric bone marrow transplant and pediatric hematology/oncology. She offers the most up-to-date diagnostic and treatment options, and she strives to partner with other care providers to provide the most comprehensive care possible.
Medical School / Education
Lake Erie College of Osteopathic Medicine, Erie, PA
Internship
Henry Ford Medical Center, Detroit, MI
Residency
Detroit Medical Center / Children's Hospital of Michigan, Detroit, MI
Fellowship
University of Michigan, Ann Arbor, MI
Pediatrics, Subspecialty-Pediatric Hematology/Oncology
American Board of Pediatrics
Academic Affiliations
Instructor, Department of Medicine, Mayo Clinic Alix School of Medicine
Assistant Clinical Professor, Department of Pediatrics, Creighton University School of Medicine
Clinical Assistant Professor, Department of Child Health, University of Arizona College of Medicine - Phoenix
Professional Affiliations
American Society of Bone Marrow Transplant
American Academy of Pediatrics,
font-size: 12px
">Arizona Chapter
Primary Immune Deficiency Treatment Consortium (PIDTC)
North American Immuno-Hematology Clinical, Educations and Research (NICER) Consortium"
Marsh RA. Leiding JW. Logan BR, Griffith LM, Arnold D, Haddad E, Falcone EL, Yin A, Patel K, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs LM, Skoda-Smith S, Chandrakasan S, Yu L, Oshrine BR, Cuvelier G, Thakar M, Chen K, Teira P, Shenoy S, Rhelen R, Forbes L, Chellapandian D, Davila Saldana B, Shah A, Weinacht K, Joshi A, Boulad F, Quigg T, Dvorak CC, Grossman D, Torgerson T, Graham P, Prasad V, Knutsen A, Chong H, Miller H, de la Morena MT, DeSantes K, Cowen MJ, Notarangelo LD, Kohn DB, Stenger E, Pai SY, Routes JM, Puck JM, Kapoor N, Pulsipher MA, Malech HL, Parikh S, Kang EM, submitted on behalf of the Primary Immune Deficiency Treatment Consortium. "Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT" J Clin Immunol. 2019 Oct;39(7):653-667. doi: 10.1007/s10875-019-00659-8. Epub 2019 Aug 2. PMID: 31376032
Zhao J, Beebe K, Magee K, Salzberg D, Stahlecker J, Miller HK, Adams RH, Lipskind S, Walsh A, Mirea L, Ngwube A. "Adolescent Male Fertility Following Reduced-intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Non-malignant Disorders" Pediatr Transplant. 2019 Sep;23(6):e13496. doi: 10.1111/petr.13496. Epub 2019 May 23. PMID: 31124253
Zhou X, O'Dwyer DN, Xia M, Miller HK, Chan PR, Trulik K, Chadwick MM, Hoffman TC, Bulte C, Bloye K, Sekerak K, Wilke CA, Patel SJ, Yokoyama WM, Murray S, Yanik GA, Moore BB. "First-Onset Herpesviral Infection and Lung Injury in Allogeneic Hematopoietic Cell Transplantation" Am J Respir Crit Care Med. 2019 Jul 1;200(1):63-74. doi: 10.1164/rccm.201809-1635OC. PMID: 30742492
Hess, J, Su L, Nizzi F, Beebe K, Magee K, Salzberg D, Stahlecker J, Miller HK, Adams RH, Ngwube A. "Successful Treatment of Severe Refractory Autoimmune Hemolytic Anemia Following Hematopietic Stem Cell Transplant with Abatacept" Transfusion. 2018 Sep;58(9):2122-2127. doi: 10.1111/trf.14907. Epub 2018 Sep 4. PMID: 30179262
Miller HK, Hanley P, Lang H, Lazarski C, Williams E, McCormack S, Roesch L, Albihani S, Dean M, Hoq F, Adams RH, Bollard C, Keller MD. "Antiviral T Cells for Adenovirus in the Pretransplant Period: a Bridge Therapy for Severe Combined Immunodeficiency" Biol Blood Marrow Transplant. 2018 Sep;24(9):1944-1946. doi: 10.1016/j.bbmt.2018.04.030. Epub 2018 May 9. PMID: 29753156
Beebe K, Magee K, McNulty A, Stahlecker J, Salzberg D, Miller H, Mirea L, Adams R, Ngwube A. "Vitamin D Deficiency and Outcomes in Pediatric Hematopoietic Stem Cell Transplantation" Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26817. Epub 2017 Sep 27. PMID: 28960811
Miller HK, Braun T, Stillwell T, Harris A, Choi S, Connelly J, Couriel D, Goldstein S, Kitko C, Magenau J, Pawarode A, Reddy P, Riwes M, Yanik G, Levine J. "Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation" Biol Blood Marrow Transplant. 2017 Mar;23(3):522-528. doi: 10.1016/j.bbmt.2016.12.630. Epub 2016 Dec 22. PMID: 28017733
Levine JE, Braun TM, Harris AC, Holler E, Taylor A, Miller H, Magenau J, Weisdorf DJ, Ho VT, Bolanos-Meade J, Alousi AM, Ferrara JL for the Blood and Marrow Transplant Clinical Trials Network. "A Prognostic Score for Acute Graft-versus-Host Disease Based on Biomarkers: A Multicentre Study" Lancet Haematol. 2015 Jan;2(1):e21-9. doi: 10.1016/S2352-3026(14)00035-0. Epub 2014 Dec 23. PMID: 26687425
